Effect of inhibitors of plasmin, kallikrein and kinin on mortality from scalding in mice.
D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002056:Burns / Q000150:complications; D057487:Enzyme Therapy; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy*
D000614:Aminocaproates; D012459:Salicylates; D007611:Aprotinin; D010653:Phenylbutazone; D001241:Aspirin